Ahn DH, Ridinger M, Cannon TL, Mendelsohn L, et al. Onvansertib in Combination With Chemotherapy and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Single-Arm, Phase II Trial. J Clin Oncol 2024 Oct 30:JCO2401266. doi: 10.1200/JCO-24-01266.
PMID: 39475591